All News
Robert F. Kennedy Jr., Foe of Drug Makers and Regulators, Is Poised to Wield New Power
President-elect Donald Trump has encouraged him to “go wild on health” but has not made clear what role Mr. Kennedy will play.
Read MoreVery Early Abortion Non-Inferior to Standard Medication Abortion Timing
(MedPage Today) -- Initiating medication abortion early was just as effective as standard medication abortion timing, an international randomized controlled trial found.
Read MoreTracking abortion laws across the United States
Abortion is now banned in more than a dozen states, while four have banned the procedure past roughly six weeks of pregnancyThe US supreme court’s decision to overturn Roe v Wade may have abolished
Read MorePsych Congress Roundup: Digital Tx for MDD; Esketamine Rooms; PA Contributions
(MedPage Today) -- Research presented at this year's Psych Congress meeting in Boston included a randomized trial of esketamine (Spravato) monotherapy, long-term data on xanomeline and trospium chlor
Read MoreMixed Bag for Clinicians Vying for House Seats
(MedPage Today) -- The presidential election was not the only race on Tuesday -- the seats for all 435 members of the House were also up for grabs.
Read More100 Days Trapped in Inpatient Legal Limbo
(MedPage Today) -- Entering Tony's* room elicited mixed emotions. His eager face and wave were a lovely daily greeting, though sadness swiftly followed.
Read MoreMore Doctors Push Back Against Medicine's 'Workaholic' Culture
(MedPage Today) -- There's been blowback in the physician community against some perspectives in a Wall Street Journal (WSJ) article in which certain doctors lambasted a newer generation's push for b
Read MoreSTAT+: Biotech and pharma executives on what Trump and RFK Jr. could mean for the industry
STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.
Read MoreEarly-Life Sugar Restriction Reduced Diabetes, Hypertension Risk
(MedPage Today) -- SAN ANTONIO -- Limiting exposure to sugar starting in utero reduced risk and delayed onset of type 2 diabetes and hypertension in adulthood, a study showed.
Read MoreLong-Term Data Support Efficacy, Safety of New Schizophrenia Drug
(MedPage Today) -- Recently approved xanomeline and trospium chloride (Cobenfy) demonstrated long-term efficacy and safety in patients with schizophrenia, long-term results from the phase III EMERGEN
Read More